GPT Healthcare

Incorporated in 1989, GPT Healthcare Limited operates a chain of mid-sized, multi-specialty, full-service hospitals in Eastern India under the ILS Hospitals brand, providing integrated healthcare services focusing on secondary and tertiary care. Based in Kolkata, West Bengal, the company offers a range of healthcare services in over 35 specialties and super-specialties, including internal medicine and diabetology, nephrology (including kidney transplant), laparoscopic and general surgery, gynaecology and obstetrics, intensive care, gastroenterology, orthopaedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. It also offers integrated diagnostic services and pharmacies. GPT Healthcare's hospitals are located in four cities, namely Salt Lake, Kolkata (West Bengal) with a capacity of 85 beds, including 17 beds in various ICUs and HDUs (as of June 30, 2023) Agartala (Tripura) with a capacity of 205 beds (as of June 30, 2023), including 66 beds in various ICUs and HDUs Dum Dum, Kolkata (West Bengal) with a capacity of 155 beds, including 53 beds in various ICUs and HDUs as of June 30, 2023 Howrah (West Bengal) with a capacity of 116 beds, including 43 beds in various ICUs and HDUs, as of June 30, 2023. As at June 30, 2023, the company operates four multidisciplinary hospitals with a total capacity of 561 beds, offering a comprehensive range of healthcare services in over 35 specialties and super-specialties. As at June 30, 2023, the company had 1,855 employees, 85 full-time consultants, and 465 visiting consultants.

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App